These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11763492)

  • 21. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary mucinous carcinoma of the prostate after low dose rate brachytherapy.
    Murchison SC; Martens MB; Truong P; Alexander A
    Can J Urol; 2018 Apr; 25(2):9284-9287. PubMed ID: 29680008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of percentage of preradiation needle biopsies with adenocarcinoma and total radiation dose on the pathologic response of unfavorable prostate adenocarcinoma.
    Goldstein NS; Kestin LL; Vicini FA; Martinez AA
    Am J Clin Pathol; 2002 Jun; 117(6):927-34. PubMed ID: 12047145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Carcinosarcoma of the prostate. Immunophenotype, morphologic course and clinico-pathologic differential diagnosis].
    Algaba F; Sóle-Balcells FJ
    Arch Esp Urol; 1992 Oct; 45(8):779-82. PubMed ID: 1466577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
    Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
    BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
    Abdel-Wahab M; Reis IM; Hamilton K
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of brachytherapy in the treatment of localized prostate cancer. Preliminary report].
    Rodríguez Duarte C; Mattout J; Moreira O; Jiménez R
    Arch Esp Urol; 2002 Sep; 55(7):785-91. PubMed ID: 12380306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
    Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
    Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When prostate brachytherapy fails: a case report and discussion.
    Kadoch C; D'Amico AV; Matthews RH
    Oncologist; 2005; 10(10):799-805. PubMed ID: 16314290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ProstaScint for brachytherapy in localized prostate adenocarcinoma.
    Ellis RJ; Kim E; Foor R
    Expert Rev Mol Diagn; 2004 Jul; 4(4):435-41. PubMed ID: 15225091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer.
    Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Lief JH; Adamovich E
    Am J Clin Oncol; 2008 Dec; 31(6):539-44. PubMed ID: 19060584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rare malignant tumors and pseudotumors of the prostate].
    Bogomoletz WV
    Bull Cancer; 1985; 72(5):423-8. PubMed ID: 4074911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ; Chen J; Stenger A; Matzkin H
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical malpractice and prostate brachytherapy.
    Lee WR
    Brachytherapy; 2004; 3(4):237-9. PubMed ID: 15607156
    [No Abstract]   [Full Text] [Related]  

  • 36. Carcinosarcoma of the prostate with multiple metastases: case report and review of the literature.
    Subramanian VS; Coburn M; Miles BJ
    Urol Oncol; 2005; 23(3):181-3. PubMed ID: 15907718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectourethral fistula after combination radiotherapy for prostate cancer.
    Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
    Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.
    Eggener SE; Roehl KA; Yossepowitch O; Catalona WJ
    J Urol; 2006 Oct; 176(4 Pt 1):1399-403. PubMed ID: 16952643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rectal adenocarcinoma with rectoprostatic fistula following prostate brachytherapy.
    Moss BF; Peracha AM
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases.
    Parwani AV; Herawi M; Epstein JI
    Am J Surg Pathol; 2006 Oct; 30(10):1254-9. PubMed ID: 17001156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.